revyve Wound Spray

revyve Wound Spray is a topical antimicrobial wound care product developed by Kane Biotech, designed to manage chronic wounds and burns by targeting bacterial biofilms. The product utilizes Kane's proprietary **DispersinB®** technology, an enzyme-based platform that disrupts the protective biofilm matrix that often renders bacteria resistant to traditional treatments. Formulated as a non-aerosol, zero-contact gel spray, it is specifically designed for rapid application to traumatic, large-surface, and hard-to-reach wounds. The thick gel consistency allows the product to adhere strongly to the wound bed. revyve Wound Spray has received U.S. FDA 510(k) clearance and Health Canada approval, positioning it as a significant advancement in biofilm-disrupting wound management.

Brand names

revyve Wound Sprayrevyve Antimicrobial Wound Gel Spray

Other names

revyve Wound Gel Spray